PEG-MGF
Also known as: Pegylated Mechano Growth Factor
PEG-MGF is a pegylated form of MGF that provides systemic effects throughout the body. It promotes muscle cell repair and growth, especially after intense training.
Research Status
Research compound
For research purposes only. Not approved for human use. Not medical advice.
Research Areas
Side Effects
Typically resolves within 1-2 hours. Minimize by rotating injection sites, allowing solution to reach room temperature, and using proper injection technique. Apply ice if swelling persists.
May occur within 1-4 hours of injection. Usually self-resolving. Ensure adequate hydration and monitor for pattern. Discontinue if severe or persistent.
IGF-1 can enhance glucose uptake. Consume a small carbohydrate-containing snack if symptoms occur. Monitor blood glucose if diabetic or pre-diabetic.
Develops with repeated injections in the same area. Prevent by strict site rotation (minimum 1 inch spacing). If lipodystrophy develops, discontinue injections in that area for 4-6 weeks.
Reported with high-dose or prolonged IGF-1 use due to tissue expansion. Discontinue if symptoms develop and seek medical evaluation. Risk is lower with pegylated forms at standard dosing.
May occur as muscles adapt to increased growth signaling. Usually resolves within 1-2 weeks. Ensure adequate recovery and nutrition.
Uncommon with subcutaneous administration. If occurs, take with food or reduce injection volume. Discontinue if persistent.
Seek immediate medical attention if severe swelling, difficulty breathing, or systemic rash develops. May indicate allergy to pegylated compounds or peptide itself. Discontinue immediately.
IGF-1 can reduce insulin sensitivity at high doses. Monitor fasting glucose and HbA1c if using regularly. Risk is higher in individuals with insulin resistance or metabolic syndrome.
Dosing Reference
| Parameter | Value |
|---|---|
| Dose range | 200-400 mcg |
| Frequency | 2-3x weekly |
| Timing | Post-workout or on training days |
| Route | Subcutaneous |
Longer half-life than regular MGF. Systemic effects.
Research disclaimer
Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.
Reconstitution Guide
Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution
Do not shake the vial vigorously; gentle swirling prevents peptide degradation
Discard immediately if the solution appears cloudy, discolored, or contains visible particles
Use within 30 days of reconstitution when stored at 2–8°C
Do not freeze the reconstituted solution; freezing may denature the peptide
Use the PeptideVolt reconstitution calculator for your exact concentration
Molecular and Pharmacological Data
| Half-life | Approximately 6-8 hours (pegylation extends half-life compared to unmodified MGF, which is ~2-3 hours) |
PEG-MGF (pegylated Mechano Growth Factor) is a modified form of IGF-1 Ec that activates muscle satellite cells and promotes myogenic differentiation and proliferation. The pegylation (polyethylene glycol coating) extends the peptide's half-life, allowing systemic distribution throughout the body and sustained anabolic signaling in muscle tissue. It works primarily through IGF-1 receptor activation on muscle cells, triggering protein synthesis and muscle fiber growth, particularly in response to mechanical stress from resistance training.
IGF-1 Receptor Signaling (IGF-1R)
PEG-MGF binds to IGF-1 receptors on muscle cells, activating the PI3K/Akt and MAPK/ERK pathways, which promote protein synthesis, inhibit protein degradation, and enhance muscle cell survival
Satellite Cell Activation
MGF stimulates quiescent muscle satellite cells to enter the cell cycle, proliferate, and differentiate into myoblasts that fuse with existing muscle fibers or form new fibers, increasing muscle mass
mTOR Pathway Activation
IGF-1 signaling activates mTORC1, a master regulator of protein synthesis and cell growth, leading to increased ribosomal protein production and muscle hypertrophy
Angiogenesis Support
MGF promotes vascular endothelial growth factor (VEGF) expression, supporting new blood vessel formation and improved nutrient delivery to muscle tissue
- PEG-MGF is a splice variant of IGF-1 (IGF-1 Ec) that is preferentially expressed in response to mechanical loading and muscle damage
- The pegylation modification increases circulating half-life and systemic bioavailability, allowing less frequent dosing than unmodified MGF
- MGF has a higher affinity for muscle satellite cells compared to systemic IGF-1, making it particularly effective for localized muscle growth
- Efficacy is enhanced when administered post-workout, as muscle damage and mechanical stress upregulate IGF-1 receptor expression
- Unlike exogenous growth hormone, MGF does not significantly suppress endogenous GH secretion at therapeutic doses
Track your PEG-MGF research
Free account. No credit card required.
Browse the Research Library
40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.
View all peptidesResearch Use Only. All content on this page is provided for informational and educational purposes related to scientific research. PEG-MGF is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.